Get started
Author

Leiming Xia

IL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways
2016 · Yang Xia, Huimin Tao, et al. · Oncotarget · 36
PDF
miR-100-3p inhibits cell proliferation and induces apoptosis in human gastric cancer through targeting to BMPR2
2019 · Chun-Wei Peng, Ling-Xiao Yue, et al. · Cancer Cell International · 32
PDF
Abstract A014: Phase I clinical trial with PD-1/MUC1 CAR-pNK92 immunotherapy
2019 · Qiao Li, Yi Wang, et al. · Cancer Immunology Research · 21
Synergy of Dendritic Cell Vaccines and Avasimibe in Treatment of Head and Neck Cancer in Mice
2017 · Xin Chen, Qibin Song, et al. · Medical Science Monitor · 21
PDF
SHP2 inhibition enhances the anticancer effect of Osimertinib in EGFR T790M mutant lung adenocarcinoma by blocking CXCL8 loop mediated stemness
2021 · Leiming Xia, Fan Yang, et al. · Cancer Cell International · 20
PDF
Elevated expression of IL-12 and IL-23 in patients with primary immune thrombocytopenia
2014 · Qingsheng Li, Mingzhen Yang, et al. · Platelets · 20
HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells
2021 · Leiming Xia, Lu Wen, et al. · Cell chemical biology · 19
PDF
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
2016 · Casey Ager, Matthew Reilley, et al. · Journal for ImmunoTherapy of Cancer · 17
PDF
Thioridazine Sensitizes Esophageal Carcinoma Cell Lines to Radiotherapy-Induced Apoptosis In Vitro and In Vivo
2016 · Hongxia Li, Li Juan, et al. · Medical Science Monitor · 17
PDF
SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma
2024 · Yi Wang, Xue Chen, et al. · BMC Medical Genomics · 16
PDF
Pan-cancer analysis reveals the potential of hyaluronate synthase as therapeutic targets in human tumors
2023 · Xunxia Bao, Juan Ran, et al. · Heliyon · 16
PDF
Thioridazine combined with carboplatin results in synergistic inhibition of triple negative breast cancer by targeting cancer stem cells
2022 · Yi Wang, Leiming Xia, et al. · Translational Oncology · 16
Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatment
2015 · Qingsheng Li, Linjie Zhang, et al. · Medical Principles and Practice · 16
PDF
Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy
2015 · Mingzhen Yang, Leiming Xia, et al. · OncoTargets and Therapy · 13
PDF
TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes
2022 · Jian Hong, Leiming Xia, et al. · Frontiers in Oncology · 12
SFXN3 is Associated with Poor Clinical Outcomes and Sensitivity to the Hypomethylating Therapy in Non-M3 Acute Myeloid Leukemia Patients
2023 · Yuxuan Dong, Fengbo Jin, et al. · Current Gene Therapy · 11
Immunological characterization and prognostic of colon cancer evaluated by angiogenesis-related features: a computational analysis and in vitro experiments
2025 · Fei Liu, Yi Wang, et al. · Discover Oncology · 10
PDF
Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
2023 · Leiming Xia, Wanlu Tian, et al. · Signal Transduction and Targeted Therapy · 8
PDF
The clinical study on treatment of CD19‐directed chimeric antigen receptor‐modified T cells in a case of refractory Richter syndrome
2019 · Leiming Xia, Yi Wang, et al. · Cancer Medicine · 7
PDF
Abstract CT041: The clinical study on CD19-directed chimeric antigen receptor-modified T cells in patient with Richter Syndrome
2017 · Leiming Xia, Qian Chen, et al. · Cancer Research · 6
A phase I trial of combination CAR-NK92MI immunotherapy by dual targeting MUC-1 and PD-L1 for patients with relapsed or refractory solid tumors: focus on non-small cell lung cancer
2025 · Jing Lin, Wenchao Xu, et al. · BMC Pulmonary Medicine · 5
PDF
Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-specific stratification, molecular markers, and hematologic toxicities
2025 · Leiming Xia, Mengni Qu, et al. · Cancer Cell International · 5
PDF
Meta-analysis on the effectiveness and safety of venetoclax-based combination therapy with hypomethylation in acute myeloid leukemia
2025 · Yi Wang, Yingying Chen, et al. · European journal of medical research · 4
PDF
Knowledge, attitude, and practice toward leukemia in the general population and among family members of patients with leukemia: A cross-sectional study
2024 · Fengbo Jin, Wanlu Tian, et al. · Heliyon · 4
SHP2 Inhibition Benefits Epidermal Growth Factor Receptor mutated Non-Small Cell Lung Cancer Therapy
2020 · Leiming Xia, Lu Wen, et al. · Mini-Reviews in Medicinal Chemistry · 4
Works count: 44
Citation count: 364
H-index: 13
I10-index: 17
Year
Topic
Type